Patient-related variables included age [continuous variable, 5- and 10-years frequency-matching], gender, baseline B- and T-cell counts, pre-vaccination anti-spike-IgGs, cohort category [controls vs. patients], and diagnosis [myeloid neoplasm vs. lymphoid neoplasm vs. solid tumor receiving PD-L1 inhibition]. This evidence concerns the gene CD274 and lymphoid neoplasm.